Atlas Trials

Myeloproliferative Syndrome

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Myeloproliferative Syndrome

RecordFirmDate
Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm (NCT04992949)French Innovative Leukemia Organisation2022-03-23
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens (NCT04968834)Dana-Farber Cancer Institute2021-06-11
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning (NCT03852407)University of Liege2019-02-04
The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase (NCT03907436)University of California, Irvine2018-10-01
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors (NCT02508038)University of Wisconsin, Madison2016-02-12
Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS) (NCT02873832)Centre Hospitalier Universitaire Dijon2015-01-01
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02129582)Case Comprehensive Cancer Center2014-11-05
Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell (NCT01660607)Stanford University2012-02-09
Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador (NCT05825326)Sociedad de Lucha Contra el Cáncer del Ecuador2012-01-01

Track Myeloproliferative Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.